Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Paul Langevin is Associate Director of Biologics Development and Tech Transfer at Amicus Therapeutics, responsible for the development and scale up of early and late phases processes. Previously he was responsible for Clincal Manufactruing and Pilot Plant Operations at Xcellerex/GE Life sciences, a development (CDMO) in Marlborough, MA, for five years. Prior to that, he was at Genzyme (Sanofi) in Framingham, MA for 16 years. He led the tech transfer and process validation efforts for multiple biologic drug candidates, including Fabrazyme and Myozyme processes at pilot scale for commercial approval.